Thursday, January 5, 2017

BRIEF-Orexigen therapeutics anticipates filing of new drug submission for Contrave

* Anticipates filing of new drug submission for contrave

with Health Canada by partner, Valeant Canada in Q1 2017

Source text for Eikon:

Further company coverage:

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)